ImmunoPrecise Antibodies Ownership | Who Owns ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies Ownership Summary
ImmunoPrecise Antibodies is owned by 6.42% institutional investors, 12.06% insiders, and 81.52% retail investors. Ingalls & snyder is the largest institutional shareholder, holding 5.02% of IPA shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in ImmunoPrecise Antibodies shares.
IPA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | ImmunoPrecise Antibodies | 6.42% | 12.06% | 81.52% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Nasdaq Composite Index | 17.48K | 0.06% | - |
IPA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools